Innovations In Clinical Neuroscience

Pain Management August 2016

A peer-reviewed, evidence-based journal for clinicians in the field of neuroscience

Issue link: http://innovationscns.epubxp.com/i/716904

Contents of this Issue

Navigation

Page 23 of 35

Hot Topics in Pain Management [August 2016] 24 the recommendations and the e vidence. Additionally, guidelines should be externally reviewed prior to their publication, and a procedure for guideline updating should be planned and described. 4 . The different options for the management of the condition or health issue should be clearly presented and the recommendations should be specific and unambiguous. 5) The views of the funding body and interests of the development group should been recorded and addressed. ADDITIONAL FILES Additional files 1 and 2 (PRISMA 2009 checklist [DOC 63 kb] and PRISMA 2009 flow diagram [DOC 60 kb] can be downloaded here: http://bmcanesthesiol.biomedcentral.co m/articles/10.1186/s12871-015-0150-5 AUTHORS' CONTRIBUTION YKD, LL and JL conceived the study, established the design and carried out the work. YKD, LL, YHH and KYF extracted, analyzed and interpreted the data. YKD and LL participated in data analysis. YKD wrote the first draft. All authors read and approved the final manuscript. REFERENCES 1. Graham R, Mancher M, Miller Wolman D, Greenfield S, Steinberg E, editors. Committee on standards for developing trustworthy clinical practice guidelines: Institute of Medicine. Clinical practice guidelines we can trust. Washington: National Academies Press; 2011. 2. Sabharwal S, Patel NK, Gauher S, Holloway I, Athanasiou T. High methodologic quality but poor applicability: assessment of the AAOS guidelines using the AGREE II instrument. Clin Orthop Relat Res. 2014;472(6):1982–8. 3. Horvath AR, Nagy E, Watine J. Critical appraisal of guidelines. In: Price CP, Christenson RH, editors. Evidence-based laboratory medicine: principles, practice, outcomes. 2nd ed. Washington: AACC press; 2007. p. 295–319. 4. Ward JE, Grieco V. Why we need guidelines for guidelines: a study of the quality of clinical practice guidelines in Australia. Med J Aust. 1996;165:474–6. 5. Kis E, Szegesdi I, Dobos E, Nagy E, Boda K, Kemény L, et al. Quality assessment of clinical p ractice guidelines for adaptation in burn injury. B urns. 2010;36(5):606–15. 6 . Jensen TS, Baron R, Haanpää M, Kalso E, Loeser JD, Rice AS, et al. Anew definition of neuropathic pain. Pain. 2011;152:2204–5. 7. Bouhassira D, Lante'ri-Minet M, Attal N, Laurent B , Touboul C. Prevalence of chronic pain with n europathic characteristics in the general p opulation. Pain. 2008;136:380–7. 8 . Gilron I, Baron R, Jensen T. Neuropathic pain: principles of diagnosis and treatment. Mayo Clin Proc. 2015;90(4):532–45. 9. Cruccu G, Anand P, Attal N, Garcia-Larrea L, Haanpää M, Jørum E, et al. EFNS guidelines on n europathic pain assessment. Eur J Neurol. 2 004;11(3):153–62. 1 0. Attal N, Cruccu G, Haanpää M, Hansson P, Jensen TS, Nurmikko T, et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol. 2006;13(11):1153–69. 11. Cruccu G, Aziz TZ, Garcia-Larrea L, Hansson P, J ensen TS, Lefaucheur JP, et al. EFNS g uidelines on neurostimulation therapy for n europathic pain. Eur J Neurol. 2007;14(9):952– 70. 12. Cruccu G, Sommer C, Anand P, Attal N, Baron R, Garcia-Larrea L, et al. EFNS guidelines on neuropathic pain assessment: revised 2009. Eur J Neurol. 2010;17(8):1010–8. 13. Attal N, Cruccu G, Baron R, Haanpää M, Hansson P, Jensen TS, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010;17(9):1113–e88. 14. Moulin DE, Clark AJ, Gilron I, Ware MA, Watson CP, Sessle BJ, et al. Pharmacological management of chronic neuropathic pain- consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag. 2007;12(1):13–21. 15. Mailis A, Taenzer P. Evidence-based guideline for neuropathic pain interventional treatments: spinal cord stimulation, intravenous infusions, epidural injections and nerve blocks. Pain Res Manag. 2012;17(3):150–8. 16. Moulin D, Boulanger A, Clark AJ, Clarke H, Dao T, Finley GA, et al. Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society. Pain Res Manag. 2014;19(6):328– 35. 17. Dworkin RH, O'Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain. 2007;132(3):237–51. 18. Haanpää M, Attal N, Backonja M, Baron R, B ennett M, Bouhassira D, et al. NeuPSIG g uidelines on neuropathic pain assessment. Pain. 2 011;152(1):14–27. 19. Dworkin RH, O'Connor AB, Kent J, Mackey SC, Raja SN, Stacey BR, et al. Interventional management of neuropathic pain: NeuPSIG r ecommendations. Pain. 2013;154(11):2249–61. 2 0. Centre for Clinical Practice at NICE (UK). N europathic pain: the pharmacological m anagement of neuropathic pain in adults in non-specialist settings. London: National Institute for Health and Care Excellence, (UK); 2010. 21. Centre for Clinical Practice at NICE (UK). N europathic pain: the pharmacological m anagement of neuropathic pain in adults in n on-specialist settings. London: National Institute for Health and Care Excellence, (UK); 2013. 22. Acevedo JC, Amaya A, Casasola Ode L, Chinchilla N, De Giorgis M, Florez S, et al. G uidelines for the diagnosis and management of n europathic pain: consensus of a group of Latin A merican experts. J Pain Palliat Care Pharmacother. 2009;23(3):261–81. 23. Chetty S, Baalbergen E, Bhigjee AI, Kamerman P, Ouma J, Raath R, et al. Clinical practice guidelines for management of neuropathic pain: expert panel recommendations for South Africa. S Afr Med J. 2012;102(5):312–25. 24. Bohlega S, Alsaadi T, Amir A, Hosny H, Karawagh AM, Moulin D, et al. Guidelines for the pharmacological treatment of peripheral neuropathic pain: expert panel recommendations for the Middle East region. J Int Med Res. 2010;38(2):295–317. 25. Legido-Quigley H, Panteli D, Brusamento S, Knai C, Saliba V, Turk E, et al. Clinical guidelines in the European Union: mapping the regulatory basis, development, quality control, implementation and evaluation across member states. Health Policy. 2012;107(2–3):146–56. 26. Tudor KI, Kozina PN, Marušić A. Methodological rigor and transparency of clinical practice guidelines developed by neurology professional societies in Croatia. PLoS One. 2013;8(7), e69877. 27. Huang TW, Lai JH, Wu MY, Chen SL, Wu CH, Tam KW. Systematic review of clinical practice guidelines in the diagnosis and management of thyroid nodules and cancer. BMC Med. 2013;11:191. 28. Sanclemente G, Acosta JL, Tamayo ME, Bonfill X, Alonso-Coello P. Clinical practice guidelines for treatment of acne vulgaris: a critical appraisal using the AGREE II instrument. Arch Dermatol Res. 2014;306(3):269–77.

Articles in this issue

Links on this page

Archives of this issue

view archives of Innovations In Clinical Neuroscience - Pain Management August 2016